Vemurafenib Active Not Recruiting Phase 2 Trials for Metastatic Cancers / Tumors, Solid / Hematologic Cancers Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02304809Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations